QF-1003B

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameQF-1003B

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionDopamine D1 receptor antagonistsDopamine D4 receptor antagonistsDopamine receptors antagonists +[7]

TargetsDopamine D2 receptorSerotonin (5-HT) receptorSerotonin 2a (5-HT2a) receptor +[7]

Therapy Area/IndicationsSchizophrenia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryItalySpain

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesN/A

China Registration ClassN/A

Active CompaniesN/A

Inactive Companies +[1] N/A

Active IndicationsN/A

Inactive IndicationsSchizophrenia

ATC CodeN/A